Enhancement of clonogenicity of human multiple myeloma by dendritic cells - Wikidata - awgldk - TriplyDB

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

http://www.wikidata.org/entity/Q36082990

about

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance Immune Modulation in Hematologic Malignancies Targeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modeling Cancer immunotherapy via dendritic cells Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.Advances in the understanding of myeloma bone disease and tumour growth.Immunity to stemness genes in human cancer.A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.Dendritic cell subsets in health and disease.Induction of malignant plasma cell proliferation by eosinophils Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma.Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications CD28-mediated regulation of multiple myeloma cell proliferation and survival.Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma.Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.Bone marrow microenvironment and the identification of new targets for myeloma therapy.Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma Molecular pathogenesis of multiple myeloma and its premalignant precursor.Stemness of B-cell progenitors in multiple myeloma bone marrow.MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma Interactions of tumor cells with dendritic cells: balancing immunity and tolerance Cancer stem cells in hematopoietic malignancies.Circulating clonotypic B cells in classic Hodgkin lymphoma The Janus face of dendritic cells in cancer.Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice.Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.Harnessing human dendritic cell subsets for medicine.

P2860

Q24644883-66FFE63A-EB19-43F4-90B0-AABD81CE9ACE Q26796307-2AE48450-C10B-4BE8-B240-28DB99569E02 Q27334339-5E252052-D6FB-4286-A2AD-01EF32A18775 Q29615444-4E9C2D22-EEF2-40CA-B076-B8651FF6FC1D Q30490975-F8B49492-F80C-42FB-9107-52EA228B5A85 Q33585559-F23E6004-E851-4CE2-AF47-C7333FD12F92 Q33590627-F9AA01F0-99A8-49E6-94D1-6F6780B30C2F Q33829022-101A3E7E-8DEA-4956-ADD2-9DFA45CD401D Q33943241-EF729452-E5EB-4F4A-A8D5-FEF2B671B197 Q33976734-F35FE350-EA6F-4C3E-AC53-97DDB3F82B47 Q34155848-4504B95E-9A32-4048-8C9E-038F02036839 Q34582889-0F5A9CF5-5367-4F4F-B00E-9762079D4038 Q34876626-B88952BB-06C0-4765-A6DE-48825B7B6926 Q35102323-E295BE7A-B1ED-4A02-86FC-2F941B1EA795 Q35128148-87C311FC-3276-47F8-BEAF-F65963A72D91 Q35584599-86056D5C-571A-49A1-BBC1-24B807E67512 Q35688965-F608936F-32C3-4985-BB65-ABC51DEC7B56 Q35828762-99F1DB95-712C-4B11-BA12-3D16B134CD50 Q35828826-AA61E38F-45E6-478D-83D9-34970F15DC19 Q35849249-B0FFBDEE-1204-4E35-8642-8BCD4282CC54 Q36117230-3B436569-FCCA-479C-9D89-600C7DE687FB Q36136992-C6D75B46-CE18-4FD6-9225-C7D2D5509576 Q36162703-60340463-113D-47BF-86C0-5E807F50B486 Q36229280-8ED4E045-42B5-4169-BCCE-CA0E462DDE1D Q36284584-7FEDBFCC-F265-437B-9F92-32327499AD93 Q36290238-E9AD23FE-BD6D-45D0-A666-57625B6D3735 Q36405908-DF9FA572-F125-4834-8292-CBE7C6E76929 Q36446189-42D5A6C5-FC77-45EA-A397-C6E252F2CE55 Q36447553-32F35882-E48E-45C4-AD44-B484E962A542 Q36839558-A11C12E3-CB5C-4A7E-A7E0-BB4E264FE0CF Q36915925-E312F871-C9D5-4782-9084-56883701F492 Q36975749-144682A2-DAFD-474F-A414-0DBF0FDDBE1C Q37045904-6E9BB53D-BEE7-48FF-8D82-BCA50D6A68C9 Q37237474-BC51C223-8CF8-4315-952E-FC5510F5678C Q37287170-3E3B1065-F98B-469F-BF51-598D2055ECB6 Q37377754-B3AB9877-AC44-4065-9F04-AE2886530A55 Q37396070-B108DDDB-9636-4636-9C36-B06ECC73C9BC Q37402009-4EFA06CC-9C42-4870-81FB-2FCD28A88D39 Q37407676-3B6FD5F9-F1D5-4BF6-AB7B-694D619AF67C Q37700841-AB8A94D4-40E5-472C-AEE9-297A25073D39

P2860

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

http://www.wikidata.org/entity/Q36082990

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

@ast

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

@en

type

label

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

@ast

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

@en

prefLabel

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

@ast

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

@en

P1433

Q36082990-C681093B-02AF-4106-BDFB-01FDD5E41FF0

P1476

Q36082990-7BFE488A-FA33-4608-9B8D-424A77C4DD52

P2093

Q36082990-2BC1C7B5-D014-432A-AD9C-4DEB7B027BA5

Q36082990-45DB1270-DB90-4CD1-812E-F054D12D4D86

Q36082990-611976A8-E4B7-4C74-A14F-DC25C998908B

Q36082990-91548B4C-1E66-4ED9-988D-DCD6BBEE3FA0

Q36082990-C27B90FF-4749-4202-9B03-89946893E764

Q36082990-C8D47539-A941-4454-BDC0-AF585F83A6B7

Q36082990-EECD299B-5C33-4A31-9983-2410DEC22C56

Q36082990-FC9CDFD0-D3EF-4655-8912-F0EC4558E3AB

P2860

Q36082990-033BFD53-9E13-40CF-9939-4EC5B8C11784

Q36082990-1BF8A441-653B-4201-8BA9-BF9829A7A201

Q36082990-482854E1-1DE0-46F0-8FC3-206E71A53DCA

Q36082990-5108E18C-7F6E-403B-8D00-34592DA60AC9

Q36082990-5E4205B6-54E9-4B04-A83D-23B4B5F08747

Q36082990-687E56FC-C8EC-4DDC-B5ED-410EC064CB55

Q36082990-6C4DEEAE-BF06-4F95-AC3A-9375F7850C7C

Q36082990-700AE865-3158-4433-8995-74F00E03BB46

Q36082990-737CD1B5-E98E-4345-A7BA-EA584F119810

Q36082990-77C29637-8D97-4AD7-8059-CFB07ED7F893

P304

Q36082990-A5F79D44-6A11-4187-AF29-967C29B7AA07

P31

Q36082990-29B59D54-EB30-4945-817F-7230A09A2719

P356

Q36082990-C3B93AFD-ADAE-4547-BD38-4ABC66BE5217

P407

Q36082990-FB584F33-029F-4AB7-A83E-DD57F9D9D09B

P433

Q36082990-FDDA4F75-234D-40F7-9A48-B1DB1FD238A2

P478

Q36082990-B9E9C097-02E6-4EF3-B5AC-C591EF86F8BA

P577

Q36082990-B47A938F-4167-4735-8A36-D954AE1A3CE6

P5875

Q36082990-E0E49D04-436A-4E20-9A17-61115A47A754

P698

Q36082990-1ED1024E-5F2F-47F8-84BF-501B7C7990E7

P932

Q36082990-4C042B05-E50E-4555-878B-699B9B30B8C3

P356

P1433

Journal of Experimental Medicine

P1476

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

@en

P2093

Aisha Hutchinson

http://www.w3.org/2001/XMLSchema#string

Amitabha Mazumder

http://www.w3.org/2001/XMLSchema#string

Anjli Kukreja

http://www.w3.org/2001/XMLSchema#string

David Vesole

http://www.w3.org/2001/XMLSchema#string

Kavita Dhodapkar

http://www.w3.org/2001/XMLSchema#string

Madhav V Dhodapkar

http://www.w3.org/2001/XMLSchema#string

Revathi Angitapalli

http://www.w3.org/2001/XMLSchema#string

Sundar Jagannath

http://www.w3.org/2001/XMLSchema#string

P2860

MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation

Characterization of clonogenic multiple myeloma cells

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Dendritic cells and the control of immunity

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival

Tumour-educated macrophages promote tumour progression and metastasis

Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells.

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

The biology of human lymphoid malignancies revealed by gene expression profiling.

Active immunization against cancer with dendritic cells: the near future.

P304

1859-1865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20052136

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6906923

http://www.w3.org/2001/XMLSchema#string

P698

16880256

http://www.w3.org/2001/XMLSchema#string

P932

2034506

http://www.w3.org/2001/XMLSchema#string